We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A clinical trial that will measure and gather data on the breathing patterns of children with cystic fibrosis (CF) will soon evaluate the effectiveness of VivoMetrics’ LifeShirt System specifically for pediatric patients.
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) is launching an internet search portal this fall that will provide a centralized location to access clinical trial registries and databases worldwide.
The FDA believes it is well on its way to implementing an electronic pedigree system for drug products by its 2007 goal, according to a newly released progress report on the agency's counterfeit drug initiative.
A computer simulation of a nonobese diabetic mouse could help researchers better understand Type 1 diabetes, and develop treatment and prevention therapies, the virtual mouse’s developers said.
Conor Medsystem’s UniStar cobalt chromium bare-metal coronary stent received the EU's CE mark approval for the treatment of de novo coronary artery lesions, the stent maker announced last week.
Science can show quantitatively that the protein structure of a branded biologic molecule is equivalent to the protein structure of a follow-on biologic product, a scientific expert told a recent industry conference.
Science can show quantitatively that the protein structure of a branded biologic molecule is equivalent to the protein structure of a follow-on biologic product, a scientific expert told a recent industry conference.
A coalition of eight pharmaceutical companies is gearing up a public relations campaign for the SAFE (Secure Access for Everyone) digital signature standard that will culminate in major announcements at the Drug Information Association’s annual meeting in June, a coalition spokesman said.
Novo Nordisk has won the inaugural Facility of the Year Award, presented by sponsors ISPE and Interphex at the Interphex 2005 Conference and Exhibition held in New York in late April.
Drug manufacturers are very good at problem solving, but many have difficulty preventing problems, according to two industry experts, who said companies should rely less on corrective action and more on manufacturing innovation.